Nuance seeks China approval for Ohtuvayre following Phase III trial success
The company aims to submit an NDA to China’s NMPA in the second half of 2025.
Sellas doses first paediatric subject with AML in Phase II trial of SLS009
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
AviadoBio begins Phase I/II trial of FTD-GRN gene therapy in the UK
MSD’s Phase III trial of Keytruda meets endpoint for treating ovarian cancer
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
Analysis
View More
Themes
View MoreAI-automated IVF procedures represent a new era in fertility treatment
The future of the field looks promising and could significantly change how families experience fertility treatments.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
IoT can help to reduce the burden of clinical trials on patients
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs